Safety of Antioxidants During GYN Cancer Care
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of XL999 in Patients With Previously Treated Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
- Status
- UNKNOWN
- Phase
- NA
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ovarian Screening Study
- Status
- COMPLETED
- Phase
- N/A
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
11C Topotecan PET Imaging
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Clinical Benefit of Topoisomerase Downregulation
- Status
- COMPLETED
- Phase
- PHASE1
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
- Status
- COMPLETED
- Phase
- PHASE2
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
- Status
- UNKNOWN
- Phase
- NA
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV
- Status
- COMPLETED
- Phase
- PHASE2